Glaukos (GKOS) Debt to Equity (2014 - 2021)

Glaukos (GKOS) reported Debt to Equity of $0.48 for Q2 2021, up 1.06% quarter-over-quarter from $0.47 in Q1 2021.

Glaukos (GKOS) Debt to Equity (2014 - 2021) Analysis & Trends

Glaukos (GKOS) has 5 years of Debt to Equity data on file, last reported at $0.48 in Q2 2021.

Debt to Equity for Q2 2021 came in at $0.48, changed N/A year-over-year; the trailing twelve-month figure through Jun 2021 was $0.48 (changed N/A YoY), and the FY2020 annual result was $0.13, changed N/A from the prior year.
Debt to Equity rose to $0.48 in Q2 2021 per GKOS's latest filing, from $0.47 in the prior quarter.
Over five years, Debt to Equity peaked at $0.48 in Q2 2021 and troughed at $0.13 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.65
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.64
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.57
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.42
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.06
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.71
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.95
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.27
10	Glaukos	7.55 Bn	7.45 Bn	117.23 Mn	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	0.48
Mar 31, 2021	0.47
Dec 31, 2020	0.13
Sep 30, 2016	0.03
Jun 30, 2016	0.05
Mar 31, 2016	0.08
Dec 31, 2015	0.10
Sep 30, 2015	0.13
Jun 30, 2015	0.22
Dec 31, 2014	-0.11